Accrued Liabilities - PureTech Health PLC (NASDAQ:PRTC) - Alpha Spread
P

PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 19.43 USD 0.08% Market Closed
Market Cap: 465m USD
Have any thoughts about
PureTech Health PLC?
Write Note

PureTech Health PLC
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PureTech Health PLC
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
P
PureTech Health PLC
NASDAQ:PRTC
Accrued Liabilities
$29.5m
CAGR 3-Years
48%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.2B
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$13.7B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.9B
CAGR 3-Years
26%
CAGR 5-Years
22%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
5%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is PureTech Health PLC's Accrued Liabilities?
Accrued Liabilities
29.5m USD

Based on the financial report for Dec 31, 2023, PureTech Health PLC's Accrued Liabilities amounts to 29.5m USD.

What is PureTech Health PLC's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
21%

Over the last year, the Accrued Liabilities growth was 12%. The average annual Accrued Liabilities growth rates for PureTech Health PLC have been 48% over the past three years , 21% over the past five years .

Back to Top